Ciphergen Announces Receipt of Deficiency Notification from Nasdaq
May 31 2006 - 5:30PM
PR Newswire (US)
FREMONT, Calif., May 31 /PRNewswire-FirstCall/ -- Ciphergen
Biosystems, Inc. (NASDAQ:CIPH) (the "Company") announced today that
on May 24, 2006 the Nasdaq Listings Qualification Department
("Nasdaq") notified the Company that it has failed to comply with
the continued listing requirements of The Nasdaq National Market
because the market value of the Company's listed securities has
fallen below $50,000,000 for 10 consecutive business days (pursuant
to Rule 4450(b)(1)(A) of the Nasdaq Marketplace Rules). Pursuant to
Nasdaq Marketplace Rule 4450(e)(4), the Company was provided a
period of 30 calendar days, or until June 23, 2006, to regain
compliance. About Ciphergen Ciphergen is dedicated to translating
protein biomarkers and panels of biomarkers into protein molecular
diagnostic tests that improve patient care. We are also focused on
providing collaborative R&D services through our Biomarker
Discovery Center(R) laboratories for biomarker discovery for new
diagnostic tests as well as pharmacoproteomic services for improved
drug toxicology, efficacy and theranostic assays. Ciphergen
develops, manufactures and markets a family of ProteinChip(R)
Systems and services for clinical, research and process proteomics
applications. ProteinChip Systems enable protein discovery,
validation, identification and assay development to provide
researchers with predictive, multi-marker assay capabilities and a
better understanding of biological function at the protein level.
Additional information about Ciphergen can be found at
http://www.ciphergen.com/. NOTE: Ciphergen, ProteinChip and
Biomarker Discovery Center are registered trademarks of Ciphergen
Biosystems, Inc. DATASOURCE: Ciphergen Biosystems, Inc. CONTACT:
Sue Carruthers, Investor Relations of Ciphergen Biosystems, Inc.,
+1-510-505-2297 Web site: http://www.ciphergen.com/
Copyright
Ciphergen Biosystems (NASDAQ:CIPH)
Historical Stock Chart
From May 2024 to Jun 2024
Ciphergen Biosystems (NASDAQ:CIPH)
Historical Stock Chart
From Jun 2023 to Jun 2024